Clinical Trial Update: Feasibility Study of Meso BioMatrix Device for Breast Reconstruction [NA]

View source ↗

Summary

Feasibility study update for the Meso BioMatrix device in breast reconstruction following breast cancer treatment; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Meso BioMatrix Device (MesoBioMatrix)

Snippet

Sponsor: Kensey Nash Corporation | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2019-09-10